Clinical Trials on Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Re in Korea, Democratic People's Republic of
Total 568 results
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerUnited States, Argentina, China, Korea, Republic of
-
AstraZenecaCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United Kingdom, Spain, United States, Netherlands
-
MedicalLogicKosin University Gospel HospitalUnknownCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
SanofiActive, not recruitingNon-small Cell Lung Cancer MetastaticKorea, Republic of, United States, Bulgaria, Czechia, Portugal, Spain
-
Biomea Fusion Inc.RecruitingColorectal Cancer | Pancreatic Cancer | NSCLC | Non Small Cell Lung Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | CRC | KRAS Mutation-Related Tumors | Relapsed Cancer | Refractory Cancer | Stage IV Non-small Cell Lung Cancer | Stage IV Colorectal Cancer | Stage III Non-small Cell Lung Cancer | Stage III NSCLC and other conditionsUnited States, Korea, Republic of
-
Daiichi Sankyo, Inc.CompletedAdvanced Non-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, India, Germany
-
Se-Hoon LeeRoche Pharma AG; AstraZenecaCompletedLung CancerKorea, Republic of
-
National Cancer Center, KoreaCompletedSmall Cell Lung CancerKorea, Republic of
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Switzerland, Australia
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerCanada, Spain, Australia, Singapore, Germany, Italy, Korea, Republic of, Norway, Taiwan, United States, France
-
AstraZenecaActive, not recruitingNon Small Cell Lung CancerBelgium, Korea, Republic of, Spain, United States, France
-
Merck Sharp & Dohme LLCRecruitingNon Small Cell Lung CancerUnited States, Israel, Taiwan, Korea, Republic of, Switzerland, Hong Kong
-
Daiichi SankyoRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Japan, Netherlands, Taiwan
-
National Cancer Center, KoreaRecruiting
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingNon Small Cell Lung Cancer | Nonsquamous Nonsmall Cell Neoplasm of Lung | Non Small Cell Lung Cancer Metastatic | Sensitizing EGFR Gene MutationUnited States, Korea, Republic of, Singapore, Taiwan
-
STCube, Inc.RecruitingExtensive Stage Small Cell Lung CancerUnited States, Korea, Republic of
-
National Cancer Center, KoreaBayerTerminatedSmall Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterCompleted
-
Dong-A University HospitalCompletedPancreatic Cancer | Non-small Cell Lung CancerKorea, Republic of
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerUnited States, France, Italy, Korea, Republic of, Germany, Portugal
-
Gilead SciencesArcus Biosciences, Inc.RecruitingLung Cancer | Advanced or Metastatic Non-Small-Cell Lung Cancer | Resectable Non-Small-Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Hong Kong, Israel, United Kingdom
-
National Cancer Center, KoreaUnknownCarcinoma, Non-Small-Cell Lung | Thoracic Surgery, Video-AssistedKorea, Republic of
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerChina, Taiwan, Belgium, Netherlands, Spain, Germany, Singapore, Italy, Japan, Australia, Israel, Korea, Republic of, Thailand, France
-
Chong Kun Dang PharmaceuticalCompletedSmall Cell Lung CancerKorea, Republic of
-
AstraZenecaParexelRecruitingNon-Small Cell Lung Cancer (NSCLC)Korea, Republic of, Malaysia, Taiwan, Thailand, Hong Kong, Singapore, Canada
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Singapore, Hong Kong, Canada
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerUnited Kingdom, Taiwan, Brazil, China, India, Korea, Republic of, Hong Kong
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedLung CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
BeiGeneRecruitingNon-small Cell Lung CancerChina, Georgia, Moldova, Republic of
-
Se-Hoon LeeAstraZenecaCompletedSmall Cell Lung CancerKorea, Republic of
-
National Cancer Center, KoreaUnknownLimited Disease Small Cell Lung CancerKorea, Republic of
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
National Cancer Center, KoreaPfizer; Roche Pharma AGUnknownNSCLC | Lung CancerKorea, Republic of
-
Mythic TherapeuticsRecruitingNon-Small Cell Lung Cancer | NSCLC | Advanced Non-Small Cell Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB | Advanced Non-Small Cell Squamous Lung Cancer | Advanced Non-Small Cell Non-Squamous Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, United Kingdom, Spain
-
Merck KGaA, Darmstadt, GermanyCompletedNon-small Cell Lung CancerSpain, Taiwan, Korea, Republic of, Singapore, China, Malaysia, Italy
-
Samsung Medical CenterNational Evidence-Based Healthcare Collaborating AgencyRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSpain, Taiwan, Japan, United States, France, Germany, Korea, Republic of, Malaysia
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerHong Kong, Taiwan, Philippines, China, Thailand, Indonesia, Australia, Korea, Republic of
-
Revolution Medicines, Inc.Active, not recruitingAdvanced Solid Tumor | Pancreatic Ductal Adenocarcinoma | Non-Small Cell Lung Cancer (NSCLC) | Colorectal Cancer (CRC)United States, Spain, France, Korea, Republic of, Malaysia, Taiwan, Italy, Thailand, Australia, Czechia, Singapore, Poland, Serbia
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Taiwan, Japan
-
Seagen Inc.Merck Sharp & Dohme LLCTerminatedMelanoma | Small Cell Lung Cancer | Prostate Cancer | Gastric Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Gastroesophageal Junction Adenocarcinoma | Non-small Cell Lung Cancer, Squamous | Non-small Cell Lung Cancer, Non-squamousUnited States, Korea, Republic of, Italy, United Kingdom, Australia, Taiwan
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerKorea, Republic of, China, Australia
-
National Cancer Center, KoreaPfizerCompletedLung CancerKorea, Republic of
-
National Cancer Center, KoreaCompletedLung CancerKorea, Republic of
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, France, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationSpain, United States, Korea, Republic of, Taiwan, Italy, Australia, France
-
Turning Point Therapeutics, Inc.TerminatedNon-Small Cell Lung Cancer | NSCLC | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | ALK Gene MutationUnited States, Australia, Korea, Republic of
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia